2023年6月13日

BenchSci——一个领导者在人工智能解决方案基础生命科学研究与发展(R&D)宣布了一项9500万美元(7000万美元)系列D一轮融资由世代投资管理与现有投资者的参与iNovia资本,TCV,黄金投资和f '资本。最近资金带来BenchSci总资金(1.7亿美元)提高到2.18亿美元。一轮融资将用于扩大该公司的革命性的人工智能药物发现平台,提升BenchSci——使科学家发现生物连接,大大减少试错实验和发现早期的风险。从BenchSci十大客户和提升用户能够发现新靶点和疾病迹象在22%的重点项目,减少不必要的试验40%,导致一个更高效的新时代,AI-driven药物发现。BenchSci提升平台允许科学家在临床前研究的每个阶段,无论治疗区域将无法访问,非结构化,unstandardized实验证据来自内部和外部数据源到可行的见解。使用专有的文本和基于图像的机器学习方法,提升解码和连接整个可用的生物医学研究的历史,结合客户实验和采购数据,创建一个不带偏见的客观地图的潜在生物学疾病。这种方法可以帮助科学家理解新的或现有的追求的可行性,还提供了见解如何有效地测试和提高翻译的临床试验。这节省了科学家们几周和几个月的调查和失败的试验时间,加快关键科学结论,从开始产生更有前途的追求。BenchSci的软件使用16前20名的制药公司和超过50000名科学家在全世界有超过4500的主要研究中心工作。成立于2015年,BenchSci已发展到400多名员工,最近仍被评为德勤在北美增长最快的科技公司。 KEY QUOTES: “Our focus will always be on what will drive the greatest impact for our customers. Thousands of scientists use our platform every day to move their most promising drug discovery projects forward faster. This investment is validation of the incredible work of our team and the traction we have in the market with the largest pharmaceutical and biotech companies in the world. With the industry 98% failure rate advancing medicines to patients in need, we’re grateful to partner with Generation who shares our thesis that purpose built, innovative AI must be deployed at scale within pharmaceutical R&D to solve the productivity crisis and bring novel medicines to patients years faster.” — Liran Belenzon, CEO and Co-Founder of the Canadian-based BenchSci “We believe more effective preclinical research is critical to a sustainable healthcare system – drug development is expensive and this cost is only increasing. BenchSci is an example of how AI can support existing drug development by helping scientists focus their research on the most promising areas of science. Previously, a scientist typically had to spend hundreds of hours to understand existing experiments and conclusions. With BenchSci’s models, scientists can find the same answer in minutes, accelerating drug discovery and reducing the time and cost to develop potentially life-saving drugs.” — Anthony Woolf, Growth Equity Partner at Generation Investment Management Trending on Pulse 2.0